Shows
The Comedy Vault – Stand-Up from the GreatsSimeon Goodson - I got bullied for eating a hotdog Standup ComedyIn this hilarious and unfiltered set, Simeon Goodson dives headfirst into one of the most bizarre moments of his youth: getting bullied just for eating a hotdog. What starts as a simple food choice quickly spirals into a riotous tale of peer pressure, childhood hierarchy, and how the weirdest things become social crimes when you're growing up.With his signature dry wit and sharp storytelling, Goodson turns a petty moment of ridicule into a brilliant breakdown of street logic, masculinity, and schoolyard politics. From the cafeteria to the corner store, he hilariously explores how even eating habits...
2025-08-2211 min
Heart of the TrialSeason 2, Episode 2: Designing Trials that Actually Work with Dr. Noah GoodsonSend us a textDesigning Trials that Actually Work—with Dr. Noah GoodsonWhat happens when you approach clinical research like a scientist, a strategist, and an entrepreneur—all at once?In this episode, Suzanne sits down with Dr. Noah Goodson, Principal, Strategy & Advisory at THREAD, to talk about how smarter study design and better technology can dramatically improve trial execution, patient experience, and data quality. Noah shares how he went from retinal neuroscience to rethinking decentralized trials—and why the best clinical strategi...
2025-08-1147 min
Inclusion Criteria: a Clinical Research podcastHuman Centered Design in Clinical Research w/ Dr. Noah GoodsonJohn Reites and Noah Goodson, PhD, explore the concept of human-centered design and its significance in clinical trials. They discuss the principles of human-centered design, how it can be applied in clinical research, and the importance of understanding user experiences to create effective systems. The conversation emphasizes the need for a thoughtful approach to design that prioritizes the needs of patients and stakeholders.Click here to message/text me your insights and ideas for future episodesThank you for joining Inclusion Criteria: a Clinical Research podcast hosted by me, John Reites...
2025-05-0307 min
Fantasy Football Happy Hour with Matthew BerryWeek 8 Waiver Wire: Jauan Jennings, Jaylen Warren, Tua Tagovailoa among key adds(1:10) – Matthew recounts his Week 7 sweat vs Producer Stephen in The League of Assholes as well as his near “execution” in The Show Guillotine League(7:25) – WR Waiver Wire: Jauan Jennings, Romeo Doubs, Dontayvion Wicks, Rashod Bateman, Cedric Tillman, Keon Coleman, DeMario Douglas, Jalen McMillan, Trey Palmer(33:20) – RB Waiver Wire: Alexander Mattison, Jaylen Warren, Tyler Goodson, D’Ernest Johnson, Ray Davis, Kendre Miller, Sean Tucker(38:00) – QB Waiver Wire: Tua Tagovailoa, Drake Maye, Russell Wilson, Bo Nix, Jameis Winston(43:30) – TE Waiver Wire: Cade Otton, Hunter Henry, Will Dissly, Noah Fant, Ja’Tavion Sanders(46:25) – Monday...
2024-10-2252 min
The Ringer Fantasy Football ShowWaiver Wire Pickups for Week 8 and We Talk TuaThe guys react to Tua Tagovailoa’s comments ahead of his return from injured reserve (1:50). Next, SHOWDOWN TIME! Must-add players at each position ahead of NFL Week 8 (16:08). Plus, emails (46:05)!
RB: Jaylen Warren (Steelers), Kimani Vidal (Chargers), and Tyler Goodson (Colts) (16:35)
WR: Jauan Jennings (49ers), Romeo Doubs (Packers), and Jalen Tolbert (Cardinals) (27:34)
TE: Hunter Henry (Patriots), Zach Ertz (Commanders), and Noah Fant (Seahawks) (36:59)
QB: Drake Maye (Patriots) (45:22)
D/ST: Denver Broncos, Kansas City Chiefs, and Los Angeles Chargers (45:48)
Check out our 2024 Ringer Fantasy Football Rankings here!Email us...
2024-10-2256 min
Payers, Providers, and Patients – Oh My!Enabling Widespread Adoption of Decentralized Clinical TrialsIn this episode, hosts Payal Nanavati, Jodi Daniel, and Cara Tenenbaum talk to Ben Moscovitch, Devon Adams, and Noah Goodson about recent policy developments on decentralized clinical trials (DCTs). They also discuss the Crowell Health Solutions’ white paper* on DCTs, which issues to federal agencies a number of policy recommendations to advance DCT adoption and increase clinical trial diversity.
This podcast episode features the following speakers:
Jodi Daniel is a Managing Director of Crowell Health Solutions and also is a partner in Crowell’s DC office, who leads the firm’s Digital Health Practice. She previously spent...
2024-02-2333 min
Decentralized: The Decentralized Trials & Research PodcastDo Decentralized Trials Really Impact Diversity?2022-06-07 Join us to discuss diversity in decentralized trials as we demystify and debunk the optimism, hope, and perhaps the hype around this topic. Hosts Craig Lipset and Amir Kalali were joined by Noah Goodson (THREAD) Jayne Morgan (Piedmont) for the discussion.Follow the Decentralized Trials & Research Alliance (DTRA) on LinkedIn and Twitter. Learn more about Membership and our work at www.dtra.org.
2023-12-2258 min
Matt Waldman's RSP CastFeel It or F@#k It 12.18.23: An RSP Cast with Bob Harris and Matt WaldmanA weekly phone conversation between fantasy veterans Bob Harris and Matt Waldman is a quick and dirty run-down of NFL players, units, or teams.
https://youtu.be/1XoDfdOk8PM
Topics
1. Vikings receivers with Nick Mullens
2. Jake Browning for the next two weeks - PIT/KC
3. Trey Sermon
4. Tyler Goodson
5. Tre Tucker
6. Noah Brown
7. Devin Singletary
8. Treylon Burks
9. Baker Mayfield '24
10. Elijah Higgins
11. Clyde Edwards-Helair/Jerick McKinnon
12. Kevin Harris
13. James Cook elite?
14. Bijan Robinson next year
15. Christian McCaffrey RB1 next year
16. Allen, Brown top-5 WRs: common message?
17. Brandon Aiyuk WR1 next year?
And of course, if you want to know about th...
2023-12-1800 min
Verboten#5 - It’s Not Genocide, Is It? (Featuring Sean Hannan, Noah Tipton, Jeremy Goodson, and Chuck Yu)CHECK OUT THE 2023 TRIVIA ADVENT-URE CALENDAR, AVAILABLE NOW!
Weirdly enough, the title isn't the only time a -cide comes up on this episode! Joining Jay this week:
The Oh Nos:
Sean Hannan - Check out ECG on Twitch, YouTube, and Discord!
Noah Tipton - Listen to the Midnight Drive-In Podcast!
vs.
JC Superstar:
Jeremy Goodson - Be kind!
Chuck Yu - Support your local libraries and friends' mental health!
This episode sponsored by Critical Grind Board Game Cafe and Liquid Kourage En...
2023-12-051h 13
Life Science TodayFinal EpisodeThis week, I have an announcement to make. Find out more athttps://LifeScienceTodayPodcast.comAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved...
2022-12-2004 minLife Science TodaySanofi/Takeda, UniQure & CSL, Fog Pharma, Merck + ImagoVaccine hesitancy, the most expensive gene therapy in the world, a $178M series D, and a $1.3B buyoutFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesSanofi/TakedaUniQure & CSLFog PharmaMerck + Imago About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market...
2022-11-3008 minLife Science TodayIndivior + Opiant, Regeneron + CytomX, Rezo, ProventionA $145M opioid acquisition, biobucks for the holidays, a series A, and diabetes approvalsFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesIndivior + OpiantRegeneron + CytomXRezoProventionAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science...
2022-11-2206 minLife Science TodayIntellia, Regeneron, Viatris + Oyster PointMore CRISPR data, oncology wins, and a new player in ophthalmologyFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesIntelliaRegeneronViatris + Oyster PointAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research...
2022-11-1609 minLife Science TodaySumitovant + Myovant, Thermo Fisher + Binding Site Group, Astellas & Taysha, Agios, VaxctyeBillion-dollar acquisitions, troubled waters for some biotech’s, and a prosperous outlook for othersFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesSumitovant + MyovantThermo Fisher + Binding Site GroupAstellas & TayshaAgiosVaxctyeAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market re...
2022-11-0208 minLife Science TodayFDA, AbbVie + DJS, Roche + Hookipa, KyvernaSome statistically significant guidance, seed to acquisition, some biobucks, and the CART of the future. Find out more athttps://LifeScienceTodayPodcast.comStory References FDAAbbVie + DJSRoche + HookipaKyvernaAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life...
2022-10-2608 minLife Science TodayDICE, Odyssey, Fred Hutch, Merck (MSD)One biotech is on a roll, another is moving quickly, Amazon money for cancer, and some clinical development news Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesDICEOdysseyFred HutchMerck (MSD), Merck Story 2About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the...
2022-10-1807 minLife Science TodayNested, Cellarity, Replimune, EstrellaBiotech’s with a series A, a series C, some debt financing, and there is even a Biopharma heading for a SPACFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesNested TherapeuticsCellarityReplimuneEstrella BiopharmaAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the st...
2022-10-1106 minLife Science TodayEisai + Biogen, Amylyx, Sanofi + RegeneronMajor Alzheimer’s news, an ALS approval, and expanded therapies for skin conditionsFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesEisai + BiogenAmylyxSanofi + RegeneronAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores tr...
2022-10-0407 minLife Science TodayAlnylam, Intellia, Third Harmonic, GalvanizeA $900 raise, gene therapy news, a quick IPO, and merge three for $100MFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesAlnylam, Link 2, Link 3Intellia TherapeuticsThird Harmonic BioGalvanize TherapeuticsAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech...
2022-09-2008 minLife Science TodayRevance, Velocity + MedPharmics, Arsenal, SpringWorksA critical aesthetics approval, site network buy-up, a very normal oncology biotech, and a busy week for one company. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesRevanceVelocity + MedPharmicsArsenalSpringWorks Link 1, Link 2, Link 3About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock m...
2022-09-1308 minLife Science TodayNovo + Forma, Sanofi, Boehringer Ingelheim, ArcturusA $1.1B acquisition, two FDA approvals, and grants for mRNA vaccines. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesNovo + FormaSanofiBoehringer IngelheimArcturusAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also e...
2022-09-0606 minLife Science TodayAlcon + Aerie, Novartis + Sandoz, Labcorp + RWJBHOphthalmology acquisitions, following the pharma trends, and a move in healthcare that is not technology related. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesAlcon + AerieNovartis + SandozLabcorp + RWJBHAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life S...
2022-08-3006 minLife Science TodayBluebird, Endo & Pharmacies, Genentech + Jemincare, Merck + OrnaGene therapy approval, opioid costs continue, a $650M deal, and a $3.5B RNA partnership. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesBluebirdEndo & PharmaciesGenentech + JemincareMerck + OrnaAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today...
2022-08-2308 minLife Science TodayPfizer, Cerevel, Abbott, AstraZeneca + Daiichi SankyoSpending that COVID money, brain money, Irish money, and another oncology approval. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesPfizerCerevelAbbottAstraZeneca + Daiichi SankyoAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs...
2022-08-1606 minLife Science TodayZymergen + Ginkgo, Cassava, TevaThis week, we take a break from stories of raising capital, mergers, and FDA approvals to look at the dark side of our industry. What happens when companies fail, people lie, and good drugs make bad lives? Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesZymergen + GinkgoCassavaTeva About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and a...
2022-08-0207 minLife Science TodayZyVersa, Incyte, Revolution, Frontera, CAMP4, ForSight, AuronThere’s a SPAC, expanded FDA approval, more of the common, and two Bs, two AsFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesZyVersaIncyteRevolutionFronteraCAMP4ForSightAuronAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market re...
2022-07-2608 minLife Science TodayVertex + ViaCyte, Theravance, Merck + Orion, Pliant, QimingCell therapy acquisition, royalties sold, biobucks-like deal, successful raise, and Chinese Venture Capital Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesVertex + ViaCyteTheravance BiopharmaMerck + OrionPliant Therapeutics QimingAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life...
2022-07-1907 minLife Science TodayFeed Drop - Interview with Dan AgroskinFEED DROP - Clinical Research Evolved Noah and John talk with Dan Agroskin, a managing director at a leading private equity firm with a focus on the clinical research industry. We discuss how investments shape industries, what entrepreneurs should think about private equity, and the forces that drive exceptional business growth.Find Out MoreDan AgroskinClinical Research EvolvedNoah Goodson, PhDJohn ReitesKyle RickettsAbout the ShowLife Science Today is your...
2022-07-1237 minLife Science TodayGalapagos + CellPoint + AboundBio, Radius, Ipsen + Epizyme, DEM BioDouble acquisition, private money, affordable deals, and a surprising $70M launchFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesGalapagos + CellPoint + AboundBioRadiusIpsen + EpizymeDEM Bio About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today...
2022-06-2806 minLife Science TodayAbbVie, Third Rock, Scholar Rock, Kyowa KirinCrohn’s approval, new VC round, direct offerings, and potential asset sales. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesAbbVieThird RockScholar RockKyowa Kirin About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today als...
2022-06-2205 minLife Science TodayBluebird, FDA, Resilience, Corvia, Code, Mineralys, TessaGene therapy, minor legislation, a $625M series D, and four companies raise $373M.Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesBlueBirdFDAResilienceCorvia, Code, Mineralys, Tessa About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs...
2022-06-1408 minLife Science TodayGSK + Affinivax, Pfizer – Haleon, Regeneron, Roche + ReparePharma buys, pharma splits, pharma trades, and oncology biobucks from pharmaFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesGSK + AffinivaxPfizer – HaleonRegeneronRoche + RepareAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also ex...
2022-06-0706 minLife Science TodayChimerix, Emergent, SIGA, Merck & Kelun, Inceptor, Laekna, KriyaPox progress, an oncology acquisition, and we look at $360M worth of biotech fundingFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesChimerix, Emergent, SIGA Merck & KelunInceptor, Laekna, KriyaAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life...
2022-05-2408 minLife Science TodayPfizer + Biohaven, Regulators, Lilly, BridgeBio + BMSAn $11.6B yes, $11.7B delay, drop the A1C with GLP, and a billion bio-bucksFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesPfizer + BiohavenRegulatorsLillyBridgeBio + BMSAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life...
2022-05-1707 minLife Science TodayZymeworks, Phathom, Catalyst, CenExel, Intercept + AdvanzResets for biotech, antibiotics approval not enough, continued consolidation, and a normal dealFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesZymeworksPhathomCatalystCenExelIntercept + AdvanzAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life...
2022-05-1007 minLife Science TodayMerck, Sanofi, J&J, ThermoFisher, Novo Nordisk, Eli LillyPharma Q1 reports are rolling in, COVID boost turned sustainable, and weight loss battle loomsFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesMerckSanofiJ&JThermoFisherNovo NordiskEli LillyAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market...
2022-05-0306 minLife Science TodayOrasis, Reify, Blackrock + MindXDrops for reading, a $220M raise, and an acquisition straight out of the moviesFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesOrasisReifyBlackrock + MindXAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores...
2022-04-2607 minLife Science TodayFDA, Antares + Halozyme, GSK + Sierra, AnsaThe FDA asks for more diversity, $1B for injectors, $2B for a one-trick pony, and $68M to make DNA. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesFDAAntares + HalozymeGSK + SierraAnsa BiotechnologiesAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market r...
2022-04-1907 minLife Science TodayPfizer + ReViral, Novartis, Charles River + Explora LabsViral therapies, rare disease approvals, and lab space premiumsFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesPfizer + ReViralNovartisCharles River + Explora LabsAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around...
2022-04-1207 minLife Science TodayGinkgo, Eagle + Acacia, Gilead, Taysha/Orchard/SilverbackBig compensation, mild mergers, a Kite in an updraft, and tightening the biotech beltFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesGinkgoEagle + AcaciaGileadTaysha/Orchard/SilverbackAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life...
2022-04-0509 minLife Science Today2seventy Bio, Ascendis, Apellis, Argenx$2 billion in capital raises mostly by companies that start with the letter A. Find out more athttps://LifeScienceTodayPodcast.comStory References2seventy BioAscendisApellisArgenxAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also e...
2022-03-2908 minLife Science TodayAlexion + Chugai, Biogen, Viatris, AbbVieCase closed on patents, Alzheimer’s data, generic approvals, and expanded approvals. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesAlexion + ChugaiBiogenViatrisAbbVieAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores tre...
2022-03-2304 minLife Science TodayTech-clusion, Gilead, AstraZeneca + Merck + Myriad, DNAnexusTechnology for inclusion, layoffs, oncology approvals, and $200M for a tech platform. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesGileadAstraZeneca + Merck + MyriadDNAnexus About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today...
2022-03-1708 min
BDGE Fantasy Football2022 Combine Reaction: Rookie Running Back Athletic Compsstock Noah on twitter: https://twitter.com/noahmorepartiesget your yelling amo against Noah here: https://bit.ly/3LBeYZistamps0:00 - it's rude to skip intros0:40 - kevin harris 3:17 - tyler allgeier5:00 - kenneth walker7:08 - keaontay ingram8:38 - jaylen warren9:58 - tyler goodson11:21 - kyren williams12:54 - zamir white14:01 kennedy brooks15:04 - rachaad white16:10 - isaiah spiller18:23 - breece hall...
2022-03-0820 minLife Science TodayCRISPR Pt 2, Sanofi + Adagene, AbbVie + Syndesi, AtlasWho owns CRISPR, a collaboration, the classics, and more money for biotech.Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesSanofi + AdageneAbbVie + SyndesiAtlasAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today...
2022-03-0807 minLife Science TodayIntellia + Regeneron, Purdue, AmicusCRISPR works, the opioid epidemic makes amends (sort of), and the SPAC that wasn’tFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesIntelliaPurdue PharmaAmicus SPACAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today al...
2022-03-0105 minLife Science TodayEli Lilly + Innovent Biologics, Agios, TC Biopharm, Blue Water Vaccines, MeihuaThe PD1 that lost, biopharma earns FDA approval, and the Biotech market is cool not dead Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesEli Lilly + Innovent BiologicsAgiosTC BiopharmBlue Water VaccinesMeihua About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock m...
2022-02-2209 minLife Science TodayArcellx, Intellia + Rewrite, Navitor + Janssen, ViiVDragons over unicorns, to CRISPR and beyond, spin-out-and-sell, and expanded approvals. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesArcellxIntellia + RewriteNavitor + JanssenViiV About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also e...
2022-02-0808 minLife Science TodayGenentech, Immunocore, Biogen, Eli Lilly, TenSixteenBispecific antibodies, ocular oncology, Biogen sells, Lilly Builds, and the treatment of a lifetimeFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesGenentechImmunocoreBiogenEli LillyTenSixteenAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs...
2022-02-0107 minLife Science TodayEleusis, AbbVie/Pfizer/Leo, UCB + Zogenix, Kura, GSK - UnileverPsychedelic SPACs, eczema frenzy, bio-outs without the biobucks, back on track, and the mega-deal that wasn’t Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesEleusisAbbvie/Pfizer/LeoUCB + ZogenixKuraGSK - UnileverAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the st...
2022-01-2507 minLife Science TodayScorpion & AstraZeneca, ABL & Sanofi, Vertex, Cochlear, VaxcyteOncology partners, Parkinson’s partners, expanded European Commission, expanded FDA, and bacterial vaccinesFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesScorpion & AstraZeneca ABL & SanofiVertexCochlearVaxcyteAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today al...
2022-01-1806 minLife Science TodayStryker + Vocera, Merck KGaA + Exelead, BeiGene, EikonDevices with tech enablement, nano particles, Chinese approvals, and a massive series B for biotechnologyFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesStryker + VoceraMerck KGaA + ExeleadBeiGeneEikonAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science T...
2022-01-1106 minLife Science TodayAnnouncements, Novartis + Gyroscope, Leo, BiogenWe’ve got a new name, gene therapy buyout, a lion of an approval, and an inescapable spotlight. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesNovartis + GyroscopeLeoBiogenBiogen 2About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Lif...
2022-01-0507 minLife Science TodayCSL + Vifor, Oracle + Cerner, Calliditas, Omega FundsAcquiring the acquired, EHR acquisition, first approvals, and a new fund for the new yearOriginally Published as The Niche Podcast.Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesCSL + ViforOracle + CernerCalliditasOmegaAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. You can expect highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private...
2021-12-2007 minLife Science TodayMicrosoft + Nuance, Roche + Recursion, Heron, 1E, AlvotechAntitrust AI, development AI, expanded approval, mega seeds, and biosimilar SPACsOriginally Published as The Niche Podcast.Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesMicrosoft + NuanceRoche + RecursionHeron1EAlvotech About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. You can expect highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and h...
2021-12-1307 minLife Science TodayVifor + Sanifit + Inositec, Kura, Takeda, Aadi, BioCryst, USDADouble acquisitions in Switzerland, FDA holds and what that means, CMV therapy, rare + oncology continues, BioCryst draws millions, and deer. Originally Published as The Niche Podcast.Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesVifor + Sanifit + InositecKuraDifferential SyndromeTakedaAadiBioCrystUSDAAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. You can expect highlights about new technologies, pharmaceutical mergers and...
2021-11-3008 minLife Science TodayBenchling, Labcorp, Novo Nordisk, BioMarin, AppliedVRTop dollar lab notes, lab consolidation, RNA sells, and two new approval areasOriginally Published as The Niche Podcast.Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesBenchlingLabcorpNovo NordiskBioMarinBioMarin 2AppliedVRAppliedVR 2Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodsonAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. You can expect...
2021-11-2307 minLife Science TodayJohnson & Johnson, Organon, Medicare, PharmaEssentia, Arbor Biotechnologies, Glen de VriesA giant breaks in two, acquisitions in women’s health, Medicare cost, rare approvals, more CRISPR, and a legacyOriginally Published as The Niche Podcast.Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesJohnson & JohnsonOrganonMedicarePharmaEssentiaArbor BiotechnologiesGlen de VriesAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. You can expect highlights about new technologies, pharmaceutical mergers and acquisitions, news ab...
2021-11-1609 minLife Science TodayRoche – Novartis, Alphabet, Pfizer, Parthenon, Antios, Mission Bio, Section 32Roche and Novartis part ways, Alphabet likes AI, Pfizer 89%, Series A, B, and the money that gets you thereOriginally Published as The Niche Podcast.Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesRoche - NovartisAlphabetPfizerParthenonAntiosMission BioSection 32About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. You can expect highlights about new technologies, pharmaceutical...
2021-11-0807 minLife Science TodayBonus Interview with Danielle Coe, Founder Black Women in Clinical ResearchThis week, we have a special bonus interview with Danielle Coe, founder of Black Women in Clinical Research. Danielle CoeBlack Women in Clinical ResearchOriginally Published as The Niche Podcast.Find out more athttps://LifeScienceTodayPodcast.comBackgroundDanielle Coe started her career as a lab-based scientist, after learning from a friend about work in clinical research she pivoted her goals. It wasn’t immediate, but she eventually found her way into the industry and has forged a path on th...
2021-11-0128 minLife Science TodayAdamis, Genentech, Kerecis, Zerigo, Click, AgenusUnique therapies including anti-opioid overdose, ocular implants, fish skin, UV light, digital therapeutics, and the impact of approvalsOriginally Published as The Niche Podcast.Find out more athttps://LifeScienceTodayPodcast.comStory Referenceshttps://tinyurl.com/Niche-074-1https://tinyurl.com/Niche-074-2https://tinyurl.com/Niche-074-3https://tinyurl.com/Niche-074-4https://tinyurl.com/Niche-074-5https://tinyurl.com/Niche-074-6https://tinyurl.com/Niche-074-7https://tinyurl.com/Niche-074-8About the...
2021-10-2508 minLife Science TodayEnzyvant, Charles River Laboratories, Merck (again), RegeneronThe 26-year pipeline, CMDO divestment, oncology, and movement among COVID19 Therapies Originally Published as The Niche Podcast.Find out more athttps://LifeScienceTodayPodcast.comStory References https://tinyurl.com/Niche-073-1 https://tinyurl.com/Niche-073-2 https://tinyurl.com/Niche-073-3https://tinyurl.com/Niche-073-4 https://tinyurl.com/Niche-073-5 https://tinyurl.com/Niche-073-6 About the ShowLife Science Today is your source for stories, insights, and trends across the life s...
2021-10-1808 minLife Science TodayGinkgo, Neumora, Pfizer, GSK, Intergalactic, VoyagerLess than spiffy SPACs, big brains big money, Malaria buzz, vaccines, tests, series A, and Voyager gets a renewed lease on lifeOriginally Published as The Niche Podcast.Find out more athttps://LifeScienceTodayPodcast.comStory Referenceshttps://tinyurl.com/Niche-072-1https://tinyurl.com/Niche-072-2https://tinyurl.com/Niche-072-3https://tinyurl.com/Niche-072-4https://tinyurl.com/Niche-072-5https://tinyurl.com/Niche-072-6https://tinyurl.com/Niche-072-7https://tinyurl.com/Niche-072-8
2021-10-1109 min
College Football NerdsEP21-25 Iowa vs Penn State Preview & Prediction - Computer Model#4 Penn State's rolling into town to face the #3 Ranked Iowa Hawkeyes. How will Sean Clifford and Noah Cain be able to attack this Iowa turnover machine defense? Can Petras and Goodson find some momentum at home vs a really staunch defense on the other side of the ball as well? We talk about it.
2021-10-0524 minLife Science TodayMerck (MSD), Merck KGaA, BioNTech, Kite$11.5B acquisitions, we play “Who’s on First”, COVID19 therapy news, cancer Vaccines may be on the way, and CAR T for cancer is here to stayOriginally Published as The Niche Podcast.Find out more athttps://LifeScienceTodayPodcast.comStory Referenceshttps://tinyurl.com/Niche-071-1https://tinyurl.com/Niche-071-2https://tinyurl.com/Niche-071-3https://tinyurl.com/Niche-071-4https://tinyurl.com/Niche-071-5https://tinyurl.com/Niche-071-6Music by Luke Goodson
2021-10-0409 minLife Science TodayIncyte, Cue Health, Velocity, PROCEPT, CatalentDouble approval, double acquisition, $200M for tests, $200M for prostate robots, $450M for $1B worth of gummiesOriginally Published as The Niche Podcast.Find out more athttps://LifeScienceTodayPodcast.comStory Referenceshttps://tinyurl.com/Niche-070-1https://tinyurl.com/Niche-070-2https://tinyurl.com/Niche-070-3https://tinyurl.com/Niche-070-4https://tinyurl.com/Niche-070-5https://tinyurl.com/Niche-070-6https://tinyurl.com/Niche-070-7About the ShowLife Science Today is...
2021-09-2708 minLife Science TodayLife Science Today 069 – BeiGene, Everest, Takeda, Exelixis, PerkinElmer + BioLegend, PreneticsOriginally Published as The Niche PodcastBeiGene’s oncology machine, China oncology pipelines, COVID costs, two new FDA approvals, $5B life science merger, and Hong Kong joins US SPAC party Find out more athttps://thenichepod.comStory Referenceshttps://tinyurl.com/Niche-069-1https://tinyurl.com/Niche-069-2https://tinyurl.com/Niche-069-3https://tinyurl.com/Niche-069-4https://tinyurl.com/Niche-069-5https://tinyurl.com/Niche-069-6https://tinyurl.com/Niche-069-7https://tinyurl.com/Niche-069-8...
2021-09-2009 minLife Science TodayLife Science Today 068 – Eli Lilly + ProQR, Sanofi + Kadmon, Lycia, BlueBird + 2seventy, MammothOriginally Published as The Niche Podcast$1.5B deal, $1.9B merger, protein degraders get backing, an old bird has new tricks, and another billion-dollar valuation for CRISPRFind out more athttps://thenichepod.comStory Referenceshttps://tinyurl.com/Niche-068-1 https://tinyurl.com/Niche-068-2https://tinyurl.com/Niche-068-3https://tinyurl.com/Niche-068-4https://tinyurl.com/Niche-068-5https://tinyurl.com/Niche-068-6Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodson
2021-09-1510 minLife Science TodayLife Science Today 067 – Bonus Interview With Sam Searcy – CEO of CliniStartOriginally Published as The Niche PodcastThis week, I go on vacation and give you a special bonus interview with Sam Searcy, founder and CEO of CliniStart and former NC State Senator Find out more athttps://thenichepod.comStory Referenceshttps://clinistart.com/https://www.samsearcy.com/https://www.linkedin.com/in/samuel-searcy-3462891a4/Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodsonLife Science Today is your source for stories, insights, and trends across...
2021-09-0626 minLife Science TodayLife Science Today 066 – Cassava, Reify, Humacyte, Pfizer + Moderna + FDA, AscendisOriginally Published as The Niche PodcastThe Cassava saga, Reify goes big… too big? Humacyte SPAC, vax news you already know, and a new growth hormone therapy – approved! Find out more athttps://thenichepod.comStory Referenceshttps://tinyurl.com/Niche-066-1https://tinyurl.com/Niche-066-2https://tinyurl.com/Niche-066-3https://tinyurl.com/Niche-066-4https://tinyurl.com/Niche-066-5https://tinyurl.com/Niche-066-6https://tinyurl.com/Niche-066-7Music by Luke Goodsonht...
2021-08-3009 minLife Science TodayLife Science Today 065 – Verily, Athira, Bain, Merck, GSK, AbogenOriginally Published as The Niche PodcastAlphabet buys, uncertain futures, new biotech funds, HIF-2a, PD-1, and a China Biotech emerges.Find out more athttps://thenichepod.comStory Referenceshttps://tinyurl.com/Niche-065-1 https://tinyurl.com/Niche-065-2https://tinyurl.com/Niche-065-3https://tinyurl.com/Niche-065-4https://tinyurl.com/Niche-065-5https://tinyurl.com/Niche-065-6Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodsonLife Science Today is your...
2021-08-2407 minLife Science TodayLife Science Today 064 – Jazz, GreenLight, Thermo Fisher + PPD, AbbVie + Soliton, Eliem, COVID UpdateOriginally Published as The Niche PodcastThis week, approvals for sleep and seizures across the pond, mRNA finds other SPACs, senior notes for CROs, FTC does a double take, IPOs, and boostersFind out more athttps://thenichepod.comStory Referenceshttps://tinyurl.com/Niche-064-1https://tinyurl.com/Niche-064-2https://tinyurl.com/Niche-064-3https://tinyurl.com/Niche-064-4https://tinyurl.com/Niche-064-5https://tinyurl.com/Niche-064-6https://tinyurl.com/Niche-064-7 ...
2021-08-1607 minLife Science TodayLife Science Today 063 – Medtronic, Sanofi, Adagio, Moderna, WCG, Inotiv, NAMSA, CenExelOriginally Published as The Niche PodcastDevice acquisitions, rare disease approvals, COVID success stories, and clinical research ups and downs. Find out more athttps://thenichepod.comStory Referenceshttps://tinyurl.com/Niche-063-1https://tinyurl.com/Niche-063-2https://tinyurl.com/Niche-063-3https://tinyurl.com/Niche-063-4https://tinyurl.com/Niche-063-5https://tinyurl.com/Niche-063-6https://tinyurl.com/Niche-063-7https://tinyurl.com/Niche-063-8https://tinyurl.com/Niche-063-9https://tinyurl...
2021-08-0909 minLife Science TodayLife Science Today 062 – Allergan + AbbVie, CHOP, Amgen + TeneoBio, Cidara, Viatris + Biocon, SOPHiA, Caribou, ArtoisOriginally Published as The Niche PodcastThis week, look closer – with drops, controlled gene therapy, acquisitions in antibodies, new antifungals, new biosimilars, and several IPOsFind out more athttps://thenichepod.comStory Referenceshttps://tinyurl.com/Niche-061-1https://tinyurl.com/Niche-061-2https://tinyurl.com/Niche-061-3https://tinyurl.com/Niche-061-4https://tinyurl.com/Niche-061-5https://tinyurl.com/Niche-061-6https://tinyurl.com/Niche-061-7https://tinyurl.com/Niche-061-8Music by...
2021-08-0208 minLife Science TodayLife Science Today 061 – Bonus Episode – Interview with Brazen Bio founders Shawn Carbonell and Brent WitgenOriginally Published as The Niche PodcastIn this special bonus episode, Dr. Noah Goodson sits down with biotech founders Dr. Shawn Carbonell and Dr. Brent Witgen to discuss their new founder-friendly biotech incubator Brazen Bio.Find out more athttps://thenichepod.comStory Referenceshttps://wefunder.com/brazenbio/https://www.linkedin.com/company/brazenbio/ https://www.brazen.bioMusic by Luke Goodsonhttps://www.soundcloud.com/lukegoodsonLife Science Today is your source for stories...
2021-07-3029 minLife Science TodayLife Science Today 060 – PacBio + Omniome, Eli Lilly, Adverum, Seres, Pfizer + ArvinasOriginally Published as The Niche PodcastSequencing technology, decentralized Alzheimer’s trials, busts in gene therapy and microbiomes, and a $2.4B oncology collaboration Find out more athttps://thenichepod.comStory Referenceshttps://tinyurl.com/Niche-060-1https://tinyurl.com/Niche-060-2https://tinyurl.com/Niche-060-3https://tinyurl.com/Niche-060-4https://tinyurl.com/Niche-060-5Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodsonLife Science Today is your source for stories, ins...
2021-07-2708 minLife Science TodayThe Niche Episode 060 – PacBio + Omniome, Adverum, Seres, Pfizer + ArvinasSequencing technology, decentralized Alzheimer’s trials, busts in gene therapy and microbiomes, and a $2.4B oncology collaborationLearn more athttps://thenichepod.comStory Referenceshttps://tinyurl.com/Niche-060-1https://tinyurl.com/Niche-060-2https://tinyurl.com/Niche-060-3https://tinyurl.com/Niche-060-4https://tinyurl.com/Niche-060-5Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodsonThe Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical re...
2021-07-2707 minLife Science TodayLife Science Today 059 - IRLAB + IPSEN, Merck (MSD), Pfizer, Regeneron, GSK, ErascaOriginally Published as The Niche PodcastDopamine deals, Merck vaccine approval, Epipen settlements, billions in buildings, and outsized Oncology IPO. Story Referenceshttps://tinyurl.com/Niche-059-1https://tinyurl.com/Niche-059-2https://tinyurl.com/Niche-059-3https://tinyurl.com/Niche-059-4https://tinyurl.com/Niche-059-5https://tinyurl.com/Niche-059-6https://tinyurl.com/Niche-059-7Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodsonLife Science Today is your source for stories...
2021-07-1907 minLife Science TodayLife Science Today 058 – BGI Group, Genebass, Astellas, Seagen, Parexel, Hyperfine SPACOriginally Published as The Niche PodcastMuddy waters of data privacy and genetic databases, antibody-drug conjugate approvals, unabetted wild enthusiasm for CROs, and mobile MRIs go public.Story Referenceshttps://tinyurl.com/Niche-058-1https://tinyurl.com/Niche-058-2https://tinyurl.com/Niche-058-3https://tinyurl.com/Niche-058-4https://tinyurl.com/Niche-058-5Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodsonAbout The Niche PodcastLife Science Today is...
2021-07-1208 minLife Science TodayLife Science Today 057 – Bonus Interview with Dr. Jayne Morgan, Executive Director COVID19 Task ForceOriginally Published as The Niche PodcastWelcome to a special bonus episode as we kick off Season 2 the Niche Podcast. I sat down with Dr. Jayne Morgan, the head of the COVID19 task force at Piedmont Healthcare to talk about her career in clinical research. Sponsorshttps://www.thescopemethod.comDr. Morgan on LinkedInhttps://tinyurl.com/Niche-057-1Dr. Morgan on Instagramhttps://tinyurl.com/Niche-057-2Music by Luke Goodsonhttps://www.soundcloud.c...
2021-07-0637 minLife Science TodayLife Science Today 056 – End of Season 1, Biogen, Pfizer, Eli Lilly, Intellia (CRISPR)Originally Published as The Niche PodcastThis is the last episode of Season 1 of the Niche Podcast. In line with that, I’ve got some announcements right at the top of the episode. Also, this week, congressional brakes, internal brakes, FDA brakes, and the first human CRISPR data. Story Referenceshttps://tinyurl.com/Niche-056-1https://tinyurl.com/Niche-056-2https://tinyurl.com/Niche-056-3https://tinyurl.com/Niche-056-4Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodsonLi...
2021-06-2809 minLife Science TodayLife Science Today 055 – Kidney Foundation, Elanco + Kindred Bio, Danaher + Aldevron, Verve, LyellOriginally Published as The Niche PodcastKidney research, pet health, manufacturing is valuable, and a couple of biotech IPOsSponsorshttps://www.thescopemethod.comStory Referenceshttps://tinyurl.com/Niche-055-1https://tinyurl.com/Niche-055-2https://tinyurl.com/Niche-055-3https://tinyurl.com/Niche-055-4https://tinyurl.com/Niche-055-5Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodsonLife Science Today is your source for stories, insights, and trends across the life...
2021-06-2109 minLife Science TodayLife Science Today 054 – Aduhelm + Alzheimer’s, Regeneron Execs, CROS NT + Alira Health, FDA RecallOriginally Published as The Niche PodcastWe dive deep into Alzheimer’s, Regeneron execs might be overpaid, a merger in clinical research, and the FDA issues a Class 1 recallSponsorshttps://www.thescopemethod.comStory Referenceshttps://tinyurl.com/Niche-054-1https://tinyurl.com/Niche-054-2https://tinyurl.com/Niche-054-3https://tinyurl.com/Niche-054-4https://tinyurl.com/Niche-054-5 Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodsonLife Science Today is you...
2021-06-1409 minLife Science TodayLife Science Today 053 – All About FDA ApprovalsOriginally Published as The Niche PodcastPending FDA approvals, expanded FDA approvals, new FDA approvals, and a lawsuit about FDA approvals.Sponsorshttps://www.thescopemethod.comStory Referenceshttps://tinyurl.com/Niche-053-1https://tinyurl.com/Niche-053-2https://tinyurl.com/Niche-053-3https://tinyurl.com/Niche-053-4https://tinyurl.com/Niche-053-5https://tinyurl.com/Niche-053-6Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodsonLife Science Today is your source...
2021-06-0709 minLife Science TodayLife Science Today 052 – AstraZeneca + Alexion, Lyell, Myovant, Foresee, GSK + VirOriginally Published as The Niche PodcastM&A Speed Bumps, “Normal” IPO but not approach, two updates, and FDA gives nod to menstrual bleeding, prostate cancer, and COVID19 monoclonal antibodies.Sponsorshttps://www.thescopemethod.comStory Referenceshttps://tinyurl.com/Niche-052-1https://tinyurl.com/Niche-052-2https://tinyurl.com/Niche-052-3ahttps://tinyurl.com/Niche-052-4https://tinyurl.com/Niche-052-5https://tinyurl.com/Niche-052-6https://tinyurl.com/Niche-052-7Music by Luke Good...
2021-05-3109 minLife Science TodayLife Science Today 051 – Oncology Trials, CRO Industry, Annovis, JanssenOriginally Published as The Niche PodcastOncology on the move, an industry report looking at broader trends, good news in Alzheimer’s, and another niche oncology therapy approved. Sponsorshttps://www.thescopemethod.comStory Referenceshttps://tinyurl.com/Niche-051-1https://tinyurl.com/Niche-051-2https://tinyurl.com/Niche-051-3https://tinyurl.com/Niche-051-4https://tinyurl.com/Niche-051-5Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodsonLife Science Today is yo...
2021-05-2409 minLife Science TodayLife Science Today 050 – Apellis, Heron, AbbVie/Allergan + Soliton, Ginkgo, CarisOriginally Published as The Niche PodcastTwo FDA approvals, cellulite and tattoos, Ginkgo pulls in $2.5B, and Caris massive growth equity for oncology testing. Sponsorshttps://www.thescopemethod.comStory Referenceshttps://tinyurl.com/Niche-50-1https://tinyurl.com/Niche-50-2https://tinyurl.com/Niche-50-3https://tinyurl.com/Niche-50-4https://tinyurl.com/Niche-50-5https://tinyurl.com/Niche-50-6https://tinyurl.com/Niche-50-7Music by Luke Goodsonhttps://www.soundcloud.com...
2021-05-1708 minLife Science TodayLife Science Today 049 – USA, Pfizer/BioNTech, Roivant, Science 37, Regeneron, GyroscopeOriginally Published as The Niche PodcastCritical intellectual property move by Biden-Harris, Pfizer goes for full approval, SPAC 1, SPAC 2, Regeneron drops big numbers, and an IPO gets punted. Sponsorshttps://www.thescopemethod.comStory Referenceshttps://tinyurl.com/Niche-049-1https://tinyurl.com/Niche-049-2https://tinyurl.com/Niche-049-3https://tinyurl.com/Niche-049-4https://tinyurl.com/Niche-049-5https://tinyurl.com/Niche-049-6Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodson
2021-05-1009 minLife Science TodayLife Science Today 048 – (Bonus) Interview with Dr. Kalali, co-chair of DTRA and founder of CNS SummitOriginally Published as The Niche PodcastWelcome to a monthly bonus episode. I sat down with Dr. Amir Kalali, the co-chair of the Decentralized Trials & Research Alliance (DTRA) – a clinical research coalition of the most influential companies in the field to talk about decentralized research and collaborating for our success as an industry. 2:35 – From CRO to CNS Summit 10:30 – Ramping up DTRA 12:29 – The Ramp of Decentralized Trials 15:50 – What will stick after the pandemic?19:28 – How different are decentralized trials really? 22:42 – Technology traps and Hybrid Trials25:12 – How are trust networks changi...
2021-05-0541 minLife Science TodayLife Science Today 047 – FDA, AstraZeneca, BioVie, Pfizer, Vaccitech, WerewolfOriginally Published as The Niche PodcastThe FDA slaps wrists and takes names, Farxiga expands FDA approval, BioVie makes cash-light acquisition, Pfizer targets fungus, and one IPO down, another to go. Sponsorshttps://www.thescopemethod.comStory Referenceshttps://tinyurl.com/Niche-047-1https://tinyurl.com/Niche-047-2https://tinyurl.com/Niche-047-3https://tinyurl.com/Niche-047-4https://tinyurl.com/Niche-047-5https://tinyurl.com/Niche-047-6Music by Luke Goodsonhttps://www...
2021-05-0310 minLife Science TodayLife Science Today 046 – Vertex, CRISPR, Versant, GSK, Syneos + Medable, VelocityOriginally Published as The Niche PodcastBillion-dollar amendments, billion-dollar funds, GSK gets oncology nod from FDA, and two stories in clinical research. Sponsorshttps://www.thescopemethod.comStory Referenceshttps://tinyurl.com/Niche-046-1https://tinyurl.com/Niche-046-2https://tinyurl.com/Niche-046-3https://tinyurl.com/Niche-046-4https://tinyurl.com/Niche-046-5Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodsonLife Science Today is your source for stories...
2021-04-2607 minLife Science TodayLife Science Today 045 – ThermoFisher + PPD, Trodelvy 2x, DiaSorin + Luminex, Merck, Novartis, and VicariousOriginally Published as The Niche PodcastMassive acquisitions in the CRO space, Trodelvy 2x, diagnostic acquisitions, Merck closes COVID vaccine program, Xolair get’s self-injection nod, and tiny robots go for massive SPAC. Sponsorshttps://www.thescopemethod.comStory Referenceshttps://tinyurl.com/Niche-045-1https://tinyurl.com/Niche-045-2https://tinyurl.com/Niche-045-3https://tinyurl.com/Niche-045-4https://tinyurl.com/Niche-045-5https://tinyurl.com/Niche-045-6Music by Luke Goodson
2021-04-1908 minLife Science TodayLife Science Today 044 – Gilead, Bio-Techne + Asuragen, Vysioneer, AchillesOriginally Published as The Niche PodcastGilead gets FDA approval in oncology, Bio-Techne acquires Asuragen, AI for tumor targeting, and Achilles completes $175M IPO. Sponsorshttps://www.thescopemethod.comStory Referenceshttps://tinyurl.com/Niche-044-1https://tinyurl.com/Niche-044-2https://tinyurl.com/Niche-044-3https://tinyurl.com/Niche-044-4Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodsonLife Science Today is your source for stories, insights, and trends across...
2021-04-1208 minLife Science TodayLife Science Today 043 – Charles River, IQVIA, Agios, AlloyOriginally Published as The Niche PodcastCharles River acquires Retrogenix, IQVIA fully acquires Q2 Solutions, Agios sells $1.8B in oncology, and Alloy forges a $75M series C. Sponsorshttps://www.thescopemethod.com Story Referenceshttps://tinyurl.com/Niche-043-1https://tinyurl.com/Niche-043-2https://tinyurl.com/Niche-043-3https://tinyurl.com/Niche-043-4https://tinyurl.com/Niche-043-5 Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodsonLife Science Today is...
2021-04-0508 minLife Science TodayLife Science Today 042 – Interview with Dr. Benjamin Schwartz on Digital Healthcare (Bonus)Originally Published as The Niche PodcastThis is our March bonus episode. I sit down with Dr. Benjamin Schwartz an orthopedic surgeon and digital health expert. We talk digital integration, healthcare cost, and how you can get involved in the space. Sponsorshttps://www.thescopemethod.comGuest Referenceshttps://www.benschwartzmd.com/https://www.linkedin.com/in/ben-schwartz-md/Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodsonLife Science Today is your source for stories, insights, and tr...
2021-04-0147 minLife Science TodayLife Science Today 041 – NeoGenomics + Trapelo, Medtronic, Gyroscope, DesignOriginally Published as The Niche PodcastMergers in precision oncology testing, Medtronic breakthrough valve replacement, Gyroscope raises capital for AMD, and small molecule genetic treatments get $240M IPO.Sponsorshttps://www.thescopemethod.comStory Referenceshttps://tinyurl.com/Niche-041-1https://tinyurl.com/Niche-041-2https://tinyurl.com/Niche-041-3https://tinyurl.com/Niche-041-4Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodsonLife Science Today is your source for stories, insights, and...
2021-03-2907 min